Biological basis and psychiatric symptoms in frontotemporal dementia

• Published in: Psychiatry and clinical neurosciences Vol. 76; no. 8; pp. 351 - 360
• Main Authors: Mori, Kohji, Ikeda, Manabu
• Format: Journal Article
• Language: English
• Published: Melbourne John Wiley & Sons Australia, Ltd 01.08.2022; Wiley Subscription Services, Inc
• Subjects: Aphasia; Dementia; Dementia disorders; Differential diagnosis; Frontotemporal dementia; Mental disorders; Neurodegeneration; Neurodegenerative diseases
• ISSN: 1323-1316; 1440-1819
• DOI: 10.1111/pcn.13375

Frontotemporal dementia is a neurodegenerative disease characterized by focal degeneration of the frontal and temporal lobes, clinically presenting with disinhibited behavior, personality changes, progressive non‐fluent aphasia and/or impaired semantic memory. Research progress has been made in re‐organizing the clinical concept of frontotemporal dementia and neuropathological classification based on multiple accumulating proteins. Alongside this progress a list of genetic mutations or variants that are causative or increase the risk of frontotemporal dementia have been identified and some of these gene products are extensively studied. However, there are still a lot of points that need to be overcome, including lack of specific diagnostic biomarker which enable antemortem diagnosis of underlying neurodegenerative process, and lack of disease modifying therapy which could prevent disease progression. Early and precise diagnosis of frontotemporal dementia is urgently required. In this context, how to define prodromal frontotemporal dementia and early differential diagnosis from primary psychiatric disorders are also important issues. In this review we will summarize and discuss current understanding of biological basis and psychiatric symptoms in frontotemporal dementia.